Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$2.19 - $6.09 $328 - $913
-150 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$5.81 - $14.39 $348 - $863
-60 Reduced 28.57%
150 $1,000
Q2 2021

Aug 12, 2021

SELL
$17.9 - $23.29 $1,342 - $1,746
-75 Reduced 26.32%
210 $4,000
Q4 2020

Feb 11, 2021

BUY
$9.31 - $14.0 $2,653 - $3,990
285 New
285 $4,000

Others Institutions Holding GTH

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Krane Funds Advisors LLC Portfolio

Follow Krane Funds Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.